Biblio
Blockchain may have a potential to prove its value for the new US FDA regulatory requirements defined in the Drug Supply Chain Security Act (DSCSA) as innovative solutions are needed to support the highly complex pharmaceutical industry supply chain as it seeks to comply. In this paper, we examine how blockchain can be applied to meet with the security compliance requirement for the pharmaceutical supply chain. We explore the online playground of Hyperledger Composer, a set of tools for building blockchain business networks, to model the data and access control rules for the drug supply chain. Our experiment shows that this solution can provide a prototyping opportunity for compliance checking with certain limitations.